Oramed Pharmaceuticals Inc. (ORMP): Price and Financial Metrics
Oramed Pharmaceuticals Inc. (ORMP)
Today's Latest Price: $4.31 USD
Updated Jan 20 6:55pm
Add ORMP to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
ORMP Stock Summary
- The ratio of debt to operating expenses for Oramed Pharmaceuticals Inc is higher than it is for about just 7.04% of US stocks.
- ORMP's price/sales ratio is 42.4; that's higher than the P/S ratio of 93.78% of US stocks.
- With a year-over-year growth in debt of 503.77%, Oramed Pharmaceuticals Inc's debt growth rate surpasses 96.4% of about US stocks.
- If you're looking for stocks that are quantitatively similar to Oramed Pharmaceuticals Inc, a group of peers worth examining would be SYBX, CDTX, CBIO, VBLT, and MTEM.
- Visit ORMP's SEC page to see the company's official filings. To visit the company's web site, go to www.oramed.com.
ORMP Stock Price Chart Interactive Chart >
ORMP Price/Volume Stats
| Current price | $4.31 | 52-week high | $5.71 |
| Prev. close | $4.44 | 52-week low | $2.40 |
| Day low | $4.24 | Volume | 230,200 |
| Day high | $4.41 | Avg. volume | 174,092 |
| 50-day MA | $3.86 | Dividend yield | N/A |
| 200-day MA | $3.43 | Market Cap | 114.91M |
Oramed Pharmaceuticals Inc. (ORMP) Company Bio
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the use of orally ingestible capsules or pills for delivery of polypeptides. The company was founded in 2002 and is based in Jerusalem, Israel.
Loading social stream, please wait...